Computer-Assisted HIV Prevention for Young Drug Users
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00182585 |
Recruitment Status
: Unknown
Verified August 2008 by National Development and Research Institutes, Inc..
Recruitment status was: Active, not recruiting
First Posted
: September 16, 2005
Last Update Posted
: August 13, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV | Procedure: computer-based HIV, STD & Hepatitis Education Procedure: educator-delivered HIV, STD and Hepatitis education | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 56 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Computer-Assisted HIV Prevention for Young Drug Users |
Study Start Date : | August 2004 |
- HIV risk behavior
- knowledge related to HIV, Hepatitis, STDs
- behavioral intentions
- attitudes toward risk-reduction behavior
- feedback on intervention

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 13 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Aadolescents in outpatients substance abuse treatment
- Ages 13 - 18 years
- Within first month of treatment entry
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00182585
United States, New York | |
Daytop | |
Brooklyn, New York, United States, 11217 | |
St. Luke's-Hospital, CAPA Program | |
New York, New York, United States, 10025 |
Principal Investigator: | Lisa Marsch, PhD | National Development and Research Institutes, Inc. |
ClinicalTrials.gov Identifier: | NCT00182585 History of Changes |
Other Study ID Numbers: |
R01DA015964 ( U.S. NIH Grant/Contract ) |
First Posted: | September 16, 2005 Key Record Dates |
Last Update Posted: | August 13, 2008 |
Last Verified: | August 2008 |
Keywords provided by National Development and Research Institutes, Inc.:
HIV hepatitis STDs adolescents |
addiction treatment prevention HIV and related risk behavior among youth in drug treatment |